Expert Consensus Statement from the American Society of Echocardiography on Hypersensitivity Reactions to Ultrasound Enhancing Agents in Patients with Allergy to Polyethylene Glycol - 02/07/21
Doi : 10.1016/j.echo.2021.05.002
Jonathan R. Lindner, MD, FASE (Chair) a, ⁎ 
, Todd Belcik, RDCS, ACS, FASE a, Michael L. Main, MD, FASE b, Anthony Montanaro, MD c, Sharon L. Mulvagh, MD, FASE d, Joan Olson, ACS, RDCS, RVT, FASE e, Ali Olyaei, PharmD f, Thomas R. Porter, MD, FASE e, Roxy Senior, MD, FRCP g
, Todd Belcik, RDCS, ACS, FASE a, Michael L. Main, MD, FASE b, Anthony Montanaro, MD c, Sharon L. Mulvagh, MD, FASE d, Joan Olson, ACS, RDCS, RVT, FASE e, Ali Olyaei, PharmD f, Thomas R. Porter, MD, FASE e, Roxy Senior, MD, FRCP g a Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon
b Saint Luke's Mid America Heart Institute, Kansas City, Missouri
c Division of Immunology and Allergy, Oregon Health & Science University, Portland, Oregon
d Maritime Heart Center, Dalhousie University, Halifax, Nova Scotia, Canada
e Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska
f Department of Pharmacy Practice, Oregon State University, Corvallis, Oregon
g National Heart and Lung Institute, Imperial College, London, United Kingdom
∗Reprint requests: Jonathan R. Lindner, MD, FASE, Oregon Health & Science University, Division of Cardiometabolic Health, Knight Cardiovascular Institute, 3181 SW Sam Jackson Park Road, Portland, OR 97239.Oregon Health & Science UniversityDivision of Cardiometabolic HealthKnight Cardiovascular Institute3181 SW Sam Jackson Park RoadPortlandOR97239
Keywords : Ultrasound enhancing agents, MedWatch, PEG
Abbreviations : FDA, PEG, UEA
Plan
| Dr. Lindner has received research grant support from Boston Scientific, Lantheus Medical Imaging, and GE Healthcare. Dr. Porter is a member of the speaker's bureau for Northwest Imaging Forums and is a consultant/adviser to Lantheus Medical Imaging. |
© 2021
American Society of Echocardiography. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 34 - N° 7
P. 707-708 - juillet 2021 Retour au numéro
Article précédent
- Information for Readers
- Advances in Rheumatic Mitral Stenosis: Echocardiographic, Pathophysiologic, and Hemodynamic Considerations
- Jeffrey J. Silbiger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?